Trial intelligence / Profile preview

ED95 of Fospropofol Disodium for Anesthesia Induction in Elderly and Impact on Cardiac Repolarization Dynamics

ChiCTR2600117386Phase 4Not yet recruiting

Sponsor
Guiyang Fourth People's Hospital
Start
Feb 2026
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fospropofol disodium (3 arms), sponsored by Guiyang Fourth People's Hospital. Primary endpoints: ED50, ED95 and 2 more. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

fospropofol disodium

Beyond the preview

Go deeper on ChiCTR2600117386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600117386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call